---
title: "Koninklijke Philips N.V. (0LNG) Gets a Buy from DZ BANK AG"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286030602.md"
description: "DZ BANK AG has maintained a Buy rating on Koninklijke Philips N.V. (0LNG), with shares closing at €22.91. Analyst Aristotelis Moutopoulos has a price target of €26.91, indicating a 17.46% upside. The consensus among analysts is a Moderate Buy, with Barclays also supporting a Buy rating and a price target of €29.50."
datetime: "2026-05-12T03:35:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286030602.md)
  - [en](https://longbridge.com/en/news/286030602.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286030602.md)
---

# Koninklijke Philips N.V. (0LNG) Gets a Buy from DZ BANK AG

In a report released yesterday, Aristotelis Moutopoulos from DZ BANK AG maintained a Buy rating on Koninklijke Philips N.V.. The company’s shares closed last Friday at €22.91.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Moutopoulos is ranked #9444 out of 12186 analysts.

Koninklijke Philips N.V. has an analyst consensus of Moderate Buy, with a price target consensus of €26.91, a 17.46% upside from current levels. In a report released on May 7, Barclays also maintained a Buy rating on the stock with a €29.50 price target.

### Related Stocks

- [RYLPF.US](https://longbridge.com/en/quote/RYLPF.US.md)
- [PHG.US](https://longbridge.com/en/quote/PHG.US.md)
- [IHI.US](https://longbridge.com/en/quote/IHI.US.md)
- [XHE.US](https://longbridge.com/en/quote/XHE.US.md)
- [IHF.US](https://longbridge.com/en/quote/IHF.US.md)
- [BARC.UK](https://longbridge.com/en/quote/BARC.UK.md)
- [BCS.US](https://longbridge.com/en/quote/BCS.US.md)

## Related News & Research

- [RBC Capital Sticks to Its Hold Rating for Koninklijke Philips N.V. (0LNG)](https://longbridge.com/en/news/286344935.md)
- [Analyst Reaffirms Buy on PAVmed, Citing Oncology Platform Momentum and Partnerships; Price Target Maintained at $16](https://longbridge.com/en/news/286945953.md)
- [Jefferies Sticks to Their Buy Rating for Dexcom (DXCM)](https://longbridge.com/en/news/286443716.md)
- [Koninklijke Philips N.V. (0LNG) Receives a Buy from Barclays](https://longbridge.com/en/news/284601154.md)
- [Jenscare’s LuX-Valve Plus Shows Strong One-Year Results in Large Annulus Tricuspid Patients](https://longbridge.com/en/news/287144318.md)